$4.30▾ 0.46%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$-0.14cash per $1 profit
Weak
Much of its reported profit is not backed by operating cash.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
✦ The read
Oramed Pharmaceuticals Inc. turns -14¢ of every reported profit-dollar into real cash. Much of its reported profit is not backed by operating cash.
Key numbers
Valuation
EPS (TTM)$1.49
TTM (trailing 12 months, through fiscal Q4 FY2025)
Profitability
Net margin3202.5%
TTM (trailing 12 months, through fiscal Q4 FY2025)
Size
Revenue (TTM)$2.00M
TTM (trailing 12 months, through fiscal Q4 FY2025)
Recent news
Signals and key numbers are from the fiscal Q4 FY2025 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.